Literature DB >> 6141498

Placental kappa binding site : interaction with dynorphin and its possible implication in hCG secretion.

A Valette, M Tafani, G Porthe, G Pontonnier, J Cros.   

Abstract

We have previously demonstrated that human placenta contains a homogenous population of kappa binding sites. The selective interaction of dynorphin with these opiate binding sites suggests a possible physiological implication of this endogenous opioid system in the placenta physiology. Ethylketocyclazocine stimulate K+-induced hCG release. This fact favours the hypothesis of a participation of placental opiate receptor on hCG secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6141498     DOI: 10.1016/0024-3205(83)90556-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  3 in total

Review 1.  Human endometrium as a neuroendocrine tissue: expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides.

Authors:  E Zoumakis; A N Margioris; A Makrigiannakis; C Stournaras; A Gravanis
Journal:  J Endocrinol Invest       Date:  1997-03       Impact factor: 4.256

Review 2.  The placenta as a target of opioid drugs†.

Authors:  Cheryl S Rosenfeld
Journal:  Biol Reprod       Date:  2022-04-26       Impact factor: 4.161

3.  Identification of L-type calcium channels associated with kappa opioid receptors in human placenta.

Authors:  B Cemerikic; R Zamah; M S Ahmed
Journal:  J Mol Neurosci       Date:  1998-06       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.